Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 2.43M
2: EX-4.5 Instrument Defining the Rights of Security Holders HTML 103K
3: EX-23.1 Consent of Expert or Counsel HTML 32K
8: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 47K Awarded Compensation
4: EX-31.1 Certification -- §302 - SOA'02 HTML 37K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 36K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 35K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 35K
14: R1 Cover HTML 107K
15: R2 Audit Information HTML 38K
16: R3 Consolidated Balance Sheets HTML 148K
17: R4 Consolidated Balance Sheets (Parenthetical) HTML 72K
18: R5 Consolidated Statements of Operations HTML 129K
19: R6 Consolidated Statements of Convertible Preferred HTML 95K
Stock and Changes in Stockholders? Equity
20: R7 Consolidated Statements of Cash Flows HTML 161K
21: R8 Description of the Business HTML 40K
22: R9 Summary of Significant Accounting Policies HTML 120K
23: R10 Significant Risks and Uncertainties Including HTML 55K
Business and Credit Concentrations
24: R11 Accounts Receivable HTML 44K
25: R12 Revenue HTML 50K
26: R13 Inventories HTML 40K
27: R14 Marketable Securities and Fair Value Measurements HTML 189K
28: R15 Property and Equipment, Net HTML 49K
29: R16 Accrued Expenses and Other Current and Non-Current HTML 45K
Liabilities
30: R17 Leases HTML 129K
31: R18 Debt HTML 70K
32: R19 Income Taxes HTML 118K
33: R20 Stockholders' Equity HTML 49K
34: R21 Share-Based Compensation HTML 118K
35: R22 Commitments and Contingencies HTML 43K
36: R23 Business Combinations HTML 119K
37: R24 Variable Interest Entities HTML 62K
38: R25 Goodwill and Intangible Assets HTML 82K
39: R26 Net Income (Loss) Per Share HTML 74K
40: R27 Segment Information HTML 84K
41: R28 Related Party Transactions HTML 58K
42: R29 Summary of Significant Accounting Policies HTML 184K
(Policies)
43: R30 Significant Risks and Uncertainties Including HTML 53K
Business and Credit Concentrations (Tables)
44: R31 Accounts Receivable (Tables) HTML 42K
45: R32 Revenue (Tables) HTML 44K
46: R33 Inventories (Tables) HTML 40K
47: R34 Marketable Securities and Fair Value Measurements HTML 189K
(Tables)
48: R35 Property and Equipment, Net (Tables) HTML 47K
49: R36 Accrued Expenses and Other Current and Non-Current HTML 44K
Liabilities (Tables)
50: R37 Leases (Tables) HTML 96K
51: R38 Debt (Tables) HTML 50K
52: R39 Income Taxes (Tables) HTML 114K
53: R40 Share-Based Compensation (Tables) HTML 103K
54: R41 Business Combinations (Tables) HTML 102K
55: R42 Variable Interest Entities (Tables) HTML 63K
56: R43 Goodwill and Intangible Assets (Tables) HTML 88K
57: R44 Net Income (Loss) Per Share (Tables) HTML 76K
58: R45 Segment Information (Tables) HTML 81K
59: R46 Related Party Transactions (Tables) HTML 54K
60: R47 Description of the Business (Details) HTML 37K
61: R48 Summary of Significant Accounting Policies HTML 102K
(Details)
62: R49 Significant Risks and Uncertainties Including HTML 46K
Business and Credit Concentrations - Revenue
Concentration Risk (Details)
63: R50 Significant Risks and Uncertainties Including HTML 44K
Business and Credit Concentrations - Vendor
Concentration Risk (Details)
64: R51 Accounts Receivable - Summary of Accounts HTML 46K
Receivable (Details)
65: R52 Accounts Receivable - Additional Information HTML 38K
(Details)
66: R53 Revenue - Summary of Disaggregation of Revenue HTML 50K
(Details)
67: R54 Revenue - Additional Information (Details) HTML 39K
68: R55 Inventories (Details) HTML 39K
69: R56 Marketable Securities and Fair Value Measurements HTML 72K
- Summary of Investment Securities Classified as
Available-for-sale (Details)
70: R57 Marketable Securities and Fair Value Measurements HTML 56K
- Additional Information (Details)
71: R58 Marketable Securities and Fair Value Measurements HTML 82K
- Summary of Carrying Amounts of Financial
Instruments (Details)
72: R59 Marketable Securities and Fair Value Measurements HTML 45K
- Summary of Changes in Fair Value of Level 3
Warrant Liabilities (Details)
73: R60 Marketable Securities and Fair Value Measurements HTML 85K
- Summary of Assumptions used in the Valuation of
Derivative Liabilities (Details)
74: R61 Property and Equipment, Net - Summary of Property HTML 56K
and Equipment, Net (Details)
75: R62 Property and Equipment, Net - Additional HTML 34K
Information (Details)
76: R63 Accrued Expenses and Other Current and Non-Current HTML 48K
Liabilities - Summary of Accrued Expenses and
Other Current Liabilities (Details)
77: R64 Accrued Expenses and Other Current and Non-Current HTML 44K
Liabilities - Additional Information (Details)
78: R65 Leases - Additional Information (Details) HTML 54K
79: R66 Leases - Summary of Lease, Cost (Details) HTML 46K
80: R67 Leases - Summary of Lessee, Operating Lease, HTML 85K
Liability, Maturity and Finance Lease, Liability,
Fiscal Year Maturity (Details)
81: R68 Leases - Summary of Weighted Average Discount HTML 43K
Rates (Details)
82: R69 Leases - Supplemental Noncash Information Related HTML 41K
Liabilities (Details)
83: R70 Debt - Additional Information (Details) HTML 106K
84: R71 Debt - Summary of Long-Term Debt, Net of HTML 55K
Unamortized Debt Issuance Costs (Details)
85: R72 Debt - Summary of Maturities of Long-Term Debt HTML 46K
(Details)
86: R73 Income Taxes - Summary of Components of Provision HTML 60K
(Benefit) for Income Taxes (Details)
87: R74 Income Taxes - Summary of Effective Income Tax HTML 71K
Rate Reconciliation (Details)
88: R75 Income Taxes - Summary of Deferred Tax Assets and HTML 77K
Liabilities (Details)
89: R76 Income Taxes - Additional Information (Details) HTML 55K
90: R77 Income Taxes - Summary of Changes in the Amount of HTML 44K
Unrecognized Tax Benefits (Details)
91: R78 Stockholders' Equity (Details) HTML 120K
92: R79 Share-Based Compensation - Additional Information HTML 137K
(Details)
93: R80 Share-Based Compensation - Summary of Weighted HTML 51K
Average Assumptions Used in the
Black-Scholes-Merton Option-Pricing Model
(Details)
94: R81 Share-Based Compensation - Summary of Stock Option HTML 76K
Activity (Details)
95: R82 Share-Based Compensation - RSUs and RSAs, RSAs and HTML 66K
Employees Earnout Shares (Details)
96: R83 Business Combinations - Additional Information HTML 135K
(Details)
97: R84 Business Combinations - Summary of Fair Value of HTML 184K
Assets Acquired and Liabilities Assumed as Part of
the Acquisition (Details)
98: R85 Business Combinations - Summary of Business HTML 37K
Acquisition, Pro forma Information (Details)
99: R86 Variable Interest Entities - Summary of HTML 115K
Consolidated Financial Statements of VIEs
(Details)
100: R87 Goodwill and Intangible Assets - Summary of HTML 53K
Intangible Assets, Net (Details)
101: R88 Goodwill and Intangible Assets - Summary of HTML 48K
Estimated Aggregate Amortization Expense (Details)
102: R89 Goodwill and Intangible Assets - Summary of HTML 35K
Estimated Aggregate Amortization Expense -
Additional Information (Details)
103: R90 Goodwill and Intangible Assets - Goodwill HTML 45K
(Details)
104: R91 Goodwill and Intangible Assets - Changes in the HTML 44K
Carrying Amount of Goodwill (Details)
105: R92 Goodwill and Intangible Assets - Narrative HTML 43K
(Details)
106: R93 Net Income (Loss) Per Share - Summary of Basic and HTML 102K
Diluted Net Income (Loss) Per Share to Common
Stockholders (Details)
107: R94 Net Income (Loss) Per Share - Summary of HTML 52K
Computation of Diluted Net Loss Per Share
(Details)
108: R95 Segment Information - Additional Information HTML 36K
(Details)
109: R96 Segment Information - Summary of Financial HTML 74K
Information for the Company's Segments (Details)
110: R97 Segment Information - Assets (Details) HTML 51K
111: R98 Related Party Transactions (Details) HTML 62K
113: XML IDEA XML File -- Filing Summary XML 217K
116: XML XBRL Instance -- toi-20231231_htm XML 3.24M
112: EXCEL IDEA Workbook of Financial Report Info XLSX 251K
10: EX-101.CAL XBRL Calculations -- toi-20231231_cal XML 353K
11: EX-101.DEF XBRL Definitions -- toi-20231231_def XML 1.00M
12: EX-101.LAB XBRL Labels -- toi-20231231_lab XML 2.40M
13: EX-101.PRE XBRL Presentations -- toi-20231231_pre XML 1.55M
9: EX-101.SCH XBRL Schema -- toi-20231231 XSD 271K
114: JSON XBRL Instance as JSON Data -- MetaLinks 729± 1.13M
115: ZIP XBRL Zipped Folder -- 0001628280-24-013444-xbrl Zip 973K
‘EX-97.1’ — Clawback Policy re: Recovery of Erroneously Awarded Compensation
THE ONCOLOGY INSTITUTE, INC. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION
The Oncology Institute, Inc. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 17, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined herein are defined in Section 11.
1.Persons Subject
to Policy
This Policy shall apply to current and former Officers of the Company. Each Officer shall be required to sign an acknowledgment pursuant to which such Officer will agree to be bound by the terms of, and comply with, this Policy; however, any Officer’s failure to sign any such acknowledgment shall not negate the application of this Policy to the Officer.
2. Compensation Subject to Policy
This Policy shall apply to Incentive-Based Compensation received on or after the Effective Date. For purposes of this Policy, the date on which Incentive-Based Compensation is “received” shall be determined under the Applicable Rules, which generally provide that Incentive-Based Compensation is “received” in the
Company’s fiscal period during which the relevant Financial Reporting Measure is attained or satisfied, without regard to whether the grant, vesting or payment of the Incentive-Based Compensation occurs after the end of that period.
3. Recovery of Compensation
In the event that the Company is required to prepare a Restatement, the Company shall recover, reasonably promptly, the portion of any Incentive-Based Compensation that is Erroneously Awarded Compensation, unless the Committee has determined that recovery would be Impracticable. Recovery shall be required in accordance with the preceding sentence regardless of whether the applicable Officer engaged in misconduct or otherwise caused
or contributed to the requirement for the Restatement and regardless of whether or when restated financial statements are filed by the Company. For clarity, the recovery of Erroneously Awarded Compensation under this Policy will not give rise to any person’s right to voluntarily terminate employment for “good reason,” or due to a “constructive termination” (or any similar term of like effect) under any plan, program or policy of or agreement with the Company or any of its affiliates.
4. Manner of Recovery; Limitation on Duplicative Recovery
The Committee shall, in its sole discretion, determine the manner of recovery of any Erroneously Awarded Compensation, which may include,
without limitation, reduction or cancellation by the Company or an affiliate of the Company of Incentive-Based Compensation or Erroneously Awarded Compensation, reimbursement or repayment by any person subject to this Policy of the Erroneously Awarded Compensation, and, to the extent permitted by law, an offset of the Erroneously Awarded Compensation against other compensation payable by the Company or an affiliate of the Company to such person. Notwithstanding the foregoing, unless otherwise prohibited by the Applicable Rules, to the extent this Policy provides for recovery of Erroneously Awarded Compensation already recovered
by the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 or Other Recovery Arrangements, the amount of Erroneously Awarded Compensation already recovered by the Company from the recipient of such Erroneously Awarded Compensation may be credited to the amount of Erroneously Awarded Compensation required to be recovered pursuant to this Policy from such person.
5. Administration
This Policy shall be administered, interpreted and construed by the Committee, which is authorized to make all determinations necessary, appropriate or advisable for such purpose. The Board of Directors of the Company
(the “Board”) may re-vest in itself the authority to administer, interpret and construe this Policy in accordance with applicable law, and in such event references herein to the
1
|US-DOCS\137849666.22||
13463\001\10072478.v4
“Committee” shall be deemed to be references to the Board. Subject to any permitted review by the applicable national securities exchange or association pursuant to the Applicable Rules, all determinations and decisions made by the Committee pursuant to the provisions of this Policy shall be final, conclusive and binding on all persons, including the
Company and its affiliates, equityholders and employees. The Committee may delegate administrative duties with respect to this Policy to one or more directors or employees of the Company, as permitted under applicable law, including any Applicable Rules.
6. Interpretation
This Policy will be interpreted and applied in a manner that is consistent with the requirements of the Applicable Rules, and to the extent this Policy is inconsistent with such Applicable Rules, it shall be deemed amended to the minimum extent necessary to ensure compliance therewith.
7. No Indemnification; No Liability
The
Company shall not indemnify or insure any person against the loss of any Erroneously Awarded Compensation pursuant to this Policy, nor shall the Company directly or indirectly pay or reimburse any person for any premiums for third-party insurance policies that such person may elect to purchase to fund such person’s potential obligations under this Policy. None of the Company, an affiliate of the Company or any member of the Committee or the Board shall have any liability to any person as a result of actions taken under this Policy.
8. Application; Enforceability
Except as otherwise determined by
the Committee or the Board, the adoption of this Policy does not limit, and is intended to apply in addition to, any other clawback, recoupment, forfeiture or similar policies or provisions of the Company or its affiliates, including any such policies or provisions of such effect contained in any employment agreement, bonus plan, incentive plan, equity-based plan or award agreement thereunder or similar plan, program or agreement of the Company or an affiliate or required under applicable law (the “Other Recovery Arrangements”). The remedy specified in this Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in equity that may be available to the
Company or an affiliate of the Company.
9. Severability
The provisions in this Policy are intended to be applied to the fullest extent of the law; provided, however, to the extent that any provision of this Policy is found to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.
10. Amendment and Termination
The Board or the Committee may amend, modify or terminate this Policy in whole or in part at any time and from time to time
in its sole discretion. This Policy will terminate automatically when the Company does not have a class of securities listed on a national securities exchange or association.
11. Definitions
“Applicable Rules” means Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder, the listing rules of the national securities exchange or association on which the Company’s securities are listed, and any applicable rules, standards or other guidance adopted by the Securities and Exchange Commission or any national securities exchange or association on which the Company’s
securities are listed.
“Committee” means the committee of the Board responsible for executive compensation decisions comprised solely of independent directors (as determined under the Applicable Rules), or in the absence of such a committee, a majority of the independent directors serving on the Board.
2
|US-DOCS\137849666.22||
13463\001\10072478.v4
“Erroneously Awarded Compensation” means the amount of Incentive-Based Compensation received by a current or former Officer that exceeds the amount
of Incentive-Based Compensation that would have been received by such current or former Officer based on a restated Financial Reporting Measure, as determined on a pre-tax basis in accordance with the Applicable Rules.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
“Financial Reporting Measure” means any measure determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures derived wholly or in part from such measures, including GAAP, IFRS and non-GAAP/IFRS financial measures, as well as stock or share price and total equityholder return.
“GAAP”
means United States generally accepted accounting principles.
“IFRS” means international financial reporting standards as adopted by the International Accounting Standards Board.
“Impracticable” means (a) the direct costs paid to third parties to assist in enforcing recovery would exceed the Erroneously Awarded Compensation; provided that the Company (i) has made reasonable attempts to recover the Erroneously Awarded Compensation, (ii) documented such attempt(s), and (iii) provided such documentation to the relevant listing exchange or association, (b) to the extent permitted by the Applicable Rules, the recovery would violate the
Company’s home country laws pursuant to an opinion of home country counsel; provided that the Company has (i) obtained an opinion of home country counsel, acceptable to the relevant listing exchange or association, that recovery would result in such violation, and (ii) provided such opinion to the relevant listing exchange or association, or (c) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and the regulations thereunder.
“Incentive-Based Compensation” means, with respect to a Restatement, any compensation that is granted, earned, or
vested based wholly or in part upon the attainment of one or more Financial Reporting Measures and received by a person: (a) after beginning service as an Officer; (b) who served as an Officer at any time during the performance period for that compensation; (c) while the issuer has a class of its securities listed on a national securities exchange or association; and (d) during the applicable Three-Year Period.
“Officer” means each person who serves as an executive officer of the Company, as defined in Rule 10D-1(d) under the Exchange Act.
“Restatement” means an accounting restatement to correct the Company’s material noncompliance
with any financial reporting requirement under securities laws, including restatements that correct an error in previously issued financial statements (a) that is material to the previously issued financial statements or (b) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.
“Three-Year Period” means, with respect to a Restatement, the three completed fiscal years immediately preceding the date that the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare
such Restatement, or, if earlier, the date on which a court, regulator or other legally authorized body directs the Company to prepare such Restatement. The “Three-Year Period” also includes any transition period (that results from a change in the Company’s fiscal year) within or immediately following the three completed fiscal years identified in the preceding sentence. However, a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months shall be deemed a completed fiscal year.
